XML 61 R14.htm IDEA: XBRL DOCUMENT v3.20.1
Note 8 - Restricted Stock
12 Months Ended
Mar. 31, 2020
Notes to Financial Statements  
Share-based Payment Arrangement [Text Block]
(
8
)
Restricted Stock
 
On
July 28, 2006,
the Company received shareholder approval for the adoption of the
2006
Employee Equity Compensation Restricted Stock Plan (the
“2006
Employee Plan”) and the
2006
Outside Director Equity Compensation Restricted Stock Plan (the
“2006
Director Plan”). The purpose of the plans was to promote the interests of the Company by securing and retaining both employees and outside directors. The Company had reserved
1.0
million shares of common stock for issuance under the Employee Plan, and
200,000
shares of common stock for issuance under the Director Plan. In
July 2012,
the Company received shareholder approval to ratify the amendment to the Company’s Director Plan passed by the Board of Directors to increase the number of shares available for issuance under the Director Plan from
200,000
to
400,000.
Additionally, the Company received shareholder approval to ratify the amendment passed by the Board of Directors to provide for a
10%
automatic increase every year in the amount of shares available for issuance under both of the plans. In
July 2015,
the Company’s
2015
Outside Director Equity Compensation Restricted Stock Plan (
“2015
Director Plan”) became effective upon the approval of the plan by the Company’s Shareholders. The
2015
Director Plan authorizes
400,000
shares of the Company's common stock available for issuance under the plan, and provides for an automatic increase every year in the amount of shares available for issuance under the plan of
10%
of the shares authorized under the plan. In
July 2016,
the Company’s
2016
Employee Equity Compensation Restricted Stock Plan (
“2016
Employee Plan”) became effective upon the approval of the plan by the Company’s Shareholders. The
2016
Employee Plan authorizes
1,000,000
shares of the Company's Common stock available for issuance under the plan. The value of the restricted stock is determined based on the market value of the stock at the issuance date. The restriction period or forfeiture period is determined by the Company’s Board and is to be
no
less than
1
year and
no
more than
ten
years.
 
At
March 31, 2020,
the Company had
972,175
restricted common shares issued under the
2006
Employee Plan,
153,608
restricted common shares issued under the
2016
Employee Plan,
272,000
restricted common shares issued under the
2006
Director Plan, and
135,000
restricted common shares issued under the
2015
Director Plan. The majority of shares were issued subject to a restriction or forfeiture period which lapses ratably on the first, second, and
third
anniversaries of the date of grant, and the fair value of which is being amortized over the
three
-year restriction period. For the fiscal years ended
March 31, 2020,
2019,
and
2018,
the Company recognized compensation expense related to the Employee and Director Plans of
$2.8
million,
$3.1
million, and
$2.6
million, respectively. A summary of the Company’s non-vested restricted stock at
March 31, 2020
is as follows (in thousands):
 
   
Employee
Plan
Number of
Shares
   
Director
Plan
Number of
Shares
   
Both Plans
Number of
Shares
 
Non-vested restricted stock outstanding at March 31, 2019
   
82
     
68
     
150
 
Restricted stock granted
   
77
     
38
     
115
 
Restricted stock vested
   
(41
)    
(32
)    
(73
)
Restricted stock forfeited or expired
   
(9
)    
-
     
(9
)
Non-vested restricted stock outstanding at March 31, 2020
   
109
     
74
     
183
 
 
At
March 31, 2020
and
2019,
there were
182,695
and
150,017,
non-vested restricted stock shares outstanding, respectively. During the fiscal years ended
March 31, 2020
and
2019,
the Company issued, net of forfeitures,
105,925
and
72,899
restricted shares, respectively. At
March 31, 2020
and
2019,
there were
$2.6
million and
$3.9
million of unrecognized compensation cost related to the non-vested restricted stock awards, respectively, which is expected to be recognized over the remaining weighted average vesting period of
1.8
years and
1.7
years for fiscal
2020
and
2019,
respectively.